/   Home   /   Newsroom   /   Research News

Researchers Reveal Novel Function of β-arrestin1 in Regulation of Inflammasome Activity

Feb 03, 2015     Email"> PrintText Size

The molecular activation mechanism of inflammasomes remains largely unknown in spite of their well-studied function in immune response and disease development. Researchers from the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences (SIBCB) of Chinese Academy of Sciences revealed the novel function of β-arrestin1 in regulation of inflammasome activation.

β-arrestins are multifunctional proteins that play critical roles in G protein-coupled receptor signaling pathway. β-arrestin1 is also involved in autoimmune diseases such as experimental autoimmune encephalomyelitis. To explore the function of β-arrestin1 in inflammasome activation, MAO Kairui, CHEN Shuzhen, WANG Yan and their colleagues led by Prof. SUN Bing and Prof. PEI Gang at SIBCB carried out a series of experiments using β-arrestin1-deficient mice.

The researchers found that in β-arrestin1-deficient peritoneal macrophages (PMs), nucleotide-binding domain and leucine-rich repeat containing family pyrin domain–containing 3 (NLRP3) and nucleotide-binding domain and leucine-rich repeat containing family CARD domain–containing protein 4 (NLRC4) inflammasome activation were strikingly dampened.

With crosslinking assay and immunofluorescence assay, β-arrestin1 was found to promote NLRP3 and NLRC4-induced apoptosis-associated speck-like protein containing a CARD (ASC) pyroptosome formation. Mechanistic study revealed β-arrestin1 could specifically interact with NLRP3 and NLRC4, and enhance their self-oligomerization. 

In vivo, β-arrestin1 was involved in MSU-induced peritonitis model by promoting IL-1β production and neutrophils influx. During Salmonella typhimurium infection which causes severe inflammation through NLRC4 inflammasome activation, β-arrestin1 deficiency played a protective role and modulated IL-1β production.

This study suggests the positive role of β-arrestin1 in regulating NLRP3 and NLRC4 inflammasomes, which may be a potential target in the treatment of IL-1β-associated auto-inflammatory diseases. 

This work entitled “β-arrestin1 is critical for the full activation of NLRP3 and NLRC4 inflammasomes” was published on The Journal of Immunology.

The study was supported by grants from the National Natural Science Foundation of China and the 973 programs.  

 

Figure: A: NLRP3 inflammasome mediated-IL-1β production was impaired in β-arrestin1-deficient PMs; B-C: NLRC4 inflammasome mediated-IL-1β production was impaired in β-arrestin1-deficient PMs; D: Activation of absent in melanoma 2 inflammasome was intact with β-arrestin1 deficiency. PMs, peritoneal macrophages. (Image by Prof. SUN Bing’s group)

Attachment:

(Editor: CHEN Na)

Contact

SUN Bing

Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences

Phone: 86-21-54921375
E-mail: bsun@sibs.ac.cn

Related Articles

Contact Us

Copyright © 2002 - 2017 Chinese Academy of Sciences